The @OSUWexMed Cardio Pharmacy team is excited to welcome Liz Mann (PGY1 at Vanderbilt) and Marisol Wences (PGY1 at Rush Medical Center) as our PGY2 cardiology residents for 2024-25. Can’t wait for the year ahead! @CardioKp @pburcham @blais_danielle @osu_pharmacy #RxMatchDay

I’m sure I’m not the only understudy that still hears @blais_danielle voice in their head on a weekly (daily really) basis driving us to be better cardiology pharmacists. This is a much deserved distinction!!

If you’re a PGY1 pharmacy resident interested in cardiology, check out our residency! I have some spots available in PPS at Midyear next week or reach out to me directly @blais_danielle @CardioKp @pburcham

Join us for the next Cardiology PRN JC on Nov 30 @ 3 PM EST. We'll be talking IV iron in HF with PGY2 CV residents Drs. Kyndol Craver and Laura Andino as they review AFFIRM-AHF and HEART-FID. See you there! https://t.co/RFyJcqjatQ Meeting ID: 832 4240 1765, Passcode: SVZ6EHf2

Our institution implemented angiotensin-II as our preferred treatment of refractory vasoplegia following cardiac surgery. Check out our experience: https://t.co/MgKYEJPkNx

Didn’t get a chance to read the STELLAR trial? No worries! Check out our visual abstract and article summary! Remember to include #CardsJC in your tweets. https://t.co/L4U7QYFYL7

Grand slam for the lead in the 8th?!? Love the emotion in the WBC

🚨 @OSUWexMed PGY2 Ambulatory Care is entering #ASHPMatch Phase II 🚨 Please reach out or see https://t.co/beo1GypIvx for more details! NMS# 665265 #TwitteRx #AmbRx #PGY2 #Match2023 @accpambuprn @accpcardprn

We are so excited to welcome Laura Andino (Reading Hospital, Tower Health) and Kyndol Craver (Memorial Hermann Texas Medical Center) to the cardiology pharmacy family here at OSUWMC! @osu_pharmacy @pburcham @blais_danielle @CardioKp @Andinogliflozin

Fantastic work by @jessica_brumit and @AnthonyRossRx at #ACC23 There’s a lot to be proud of for @MikeCardioEPRx @blais_danielle @CardioKp @pburcham @RameshEmani @RyanCaputo1 @OSUWexMed @ACCinTouch

Awesome presentation by @AirInBags today at #ACC23

Happy Pharmacy Friday! NEW PEARL IS OUT. Read our latest Pharmacy Friday Pearl to learn more about the pharmacology and management of fibrinolytics in STEMI https://t.co/1xavjbXeds #newblog #fibrinolytics #thrombolytictherapy #STEMI #pharmacyfridaypearls #pacublogs

Interested in #PharmRes programs at Ohio State? Attend the PGY1 and PGY2 information sessions happening over the next several weeks to learn more! More info, including Zoom links, available at https://t.co/eYF0IcPEjT. #TwitteRx @OSUWexMed

🔘ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison From @jaccjournals https://t.co/G1Af4J4A8e

The prettiest summary of HF clinical trials 🫀😍 #GDMTworks #CardioTwitter @accpcardprn https://t.co/JL0leEQ1Fr

On this week's #TeachingTuesday, we have a review of DOACs in obesity by @FrancesNicole21. How do you approach #DOAC use in extremes of weight? Does the choice of drug matter? Find out more in the infographic 👇 below!

#DAPT with aspirin and an oral P2Y12 inhibitor is recommended post #PCI for 6-12 months, depending on stent type and patient-specific factors. Read the expert analysis to learn more: https://t.co/m9Eubs7xnQ #cvSurg

🚨New Guideline Alert🚨 2022 Heart Failure Guidelines thanks to @ACCinTouch @American_Heart and @HFSA What changes are you excited to see? Let us know in the comments🫀 #TwitteRx #CardioTwitter